Immunoclin (Immunoclin) Other Stockholders Equity : $-4.60 Mil (As of Oct. 2014)

View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Other Stockholders Equity?

Immunoclin's Other Stockholders Equity for the quarter that ended in Oct. 2014 was $-4.60 Mil.

Immunoclin's quarterly Other Stockholders Equity declined from Apr. 2014 ($-0.52 Mil) to Jul. 2014 ($-0.82 Mil) and declined from Jul. 2014 ($-0.82 Mil) to Oct. 2014 ($-4.60 Mil).

Immunoclin's annual Other Stockholders Equity increased from Feb. 2012 ($0.00 Mil) to Jan. 2013 ($0.00 Mil) but then declined from Jan. 2013 ($0.00 Mil) to Jan. 2014 ($0.00 Mil).

Immunoclin Other Stockholders Equity Historical Data

The historical data trend for Immunoclin's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Other Stockholders Equity Chart

Immunoclin Annual Data

Trend

Feb12

Jan13

Jan14

Other Stockholders Equity

Immunoclin Quarterly Data
	May11	Aug11	Nov11	Feb12	May12	Aug12	Nov12	Feb13	May13	Aug13	Nov13	Apr14	Jul14	Oct14
Other Stockholders Equity	Get a 7-Day Free Trial									-	-	-0.52	-0.82	-4.60

Immunoclin Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Immunoclin Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Immunoclin's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunoclin (Immunoclin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210

Website

http://www.immunoclin.com

Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines